Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Coeptis Therapeutics Holdings Inc COEP

Alternate Symbol(s):  COEPW

Healthcare Biotechnology
Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical company. The company is developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its product portfolio and rights are licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform; and DVX201, a clinical-stage, natural killer cell therapy... see more

Recent & Breaking News (NDAQ:COEP)

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates BFIN, COEP, ARIS, CIO on Behalf of Shareholders

GlobeNewswire October 7, 2025

ACT NOW: The M&A Class Action Firm Continues to Investigate the Merger - BFIN, ARIS, CIO and COEP

GlobeNewswire October 7, 2025

Vanderbilt Report: Coeptis Shows How Biotech Can Fund Itself While Innovating

GlobeNewswire September 23, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CYBR, UNP, COEP on Behalf of Shareholders

PR Newswire August 28, 2025

Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd

GlobeNewswire July 22, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAGE, COEP, AVDX on Behalf of Shareholders

GlobeNewswire July 5, 2025

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: COEP, RHE, PPBI, and PORT

PR Newswire July 3, 2025

Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared

GlobeNewswire June 26, 2025

Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology

GlobeNewswire May 28, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, PPBI, COEP on Behalf of Shareholders

PR Newswire May 6, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Skechers U.S.A., Inc. (NYSE - SKX), BioSig Technologies, Inc. (Nasdaq - BSGM), Coeptis Therapeutics Holdings, Inc. (Nasdaq - COEP), Pacific Premier Bancorp, Inc. (Nasdaq - PPBI)

GlobeNewswire May 5, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COEP and PPBI on Behalf of Shareholders

GlobeNewswire May 1, 2025

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Coeptis Therapeutics Holdings, Inc. - COEP

PR Newswire April 28, 2025

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Coeptis Therapeutics Holdings, Inc. Merger

Newsfile April 28, 2025

COEP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Coeptis Therapeutics Holdings, Inc. Is Fair to Shareholders

Business Wire April 25, 2025

Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement

GlobeNewswire April 25, 2025

COEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in Technology

GlobeNewswire April 17, 2025

Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR(TM) Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline

GlobeNewswire March 11, 2025

COEPTIS' NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan

GlobeNewswire March 7, 2025

COEPTIS' NexGenAI Partners with Arketyp Valu to Revolutionize Digital Engagement on the Verus Network

GlobeNewswire February 20, 2025